CALC
CalciMedica, Inc.
1W: -19.6%
1M: +28.1%
3M: -86.7%
YTD: -90.1%
1Y: -67.3%
$0.58
-0.16 (-21.68%)
After Hours: $0.64 (+0.06, +10.67%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$9.1M
52W Range0.461-7.2
Volume363,683
Avg Volume1,271,128
Beta1.24
Dividend—
Analyst Ratings
Company Info
CEOA. Rachel Leheny
Employees14
SectorHealthcare
IndustryBiotechnology
IPO Date2023-06-14
Websitecalcimedica.com
505 Coast Boulevard South
La Jolla, CA 92037
US
La Jolla, CA 92037
US
858-952-5500
About CalciMedica, Inc.
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.
Latest News
12 Health Care Stocks Moving In Friday's After-Market Session
CalciMedica GAAP EPS of -$1.97
12 Health Care Stocks Moving In Tuesday's Intraday Session
CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Glicklich Alan | A-Award | 937 | $3.26 | 2025-10-13 |
| Roberts Eric W | P-Purchase | 2,500 | $3.07 | 2025-09-18 |
| Roberts Eric W | P-Purchase | 3,400 | $2.68 | 2025-09-15 |
| Roberts Eric W | P-Purchase | 5,000 | $3.12 | 2025-09-12 |
| Roberts Eric W | P-Purchase | 2,343 | $3.15 | 2025-09-09 |